Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)

相似書籍

• Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
  由: Kim, Nick H, et al.
  出版: (2017)
• Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland
  由: Markku Pentikäinen, et al.
  出版: (2024-12-01)
• Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH
  由: Benza, Raymond L., et al.
  出版: (2020)
• Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
  由: Marra, Alberto M., et al.
  出版: (2018)
• Effects of riociguat in severe experimental pulmonary hypertension
  由: Kojonazarov, Baktybek, et al.
  出版: (2011)